Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of cabazitaxel in fourth or later line of therapy in metastatic castration-resistant prostate cancer: Multi-institutional real-world experience in Germany.
Wenzel M, Borkowetz A, Lieb V, Hoffmann MA, Borgmann H, Höfner T, Dotzauer R, Neuberger M, Worst TS, von Hardenberg J, Linxweiler J, Klümper N. Wenzel M, et al. Among authors: linxweiler j. Urol Oncol. 2022 Dec;40(12):538.e7-538.e14. doi: 10.1016/j.urolonc.2022.09.011. Epub 2022 Oct 14. Urol Oncol. 2022. PMID: 36244915
Active surveillance inclusion criteria under scrutiny in magnetic resonance imaging-guided prostate biopsy: a multicenter cohort study.
Kornienko K, Siegel F, Borkowetz A, Hoffmann MA, Drerup M, Lieb V, Bruendl J, Höfner T, Cash H, von Hardenberg J, Westhoff N; GESRU Academics Prostate Cancer Group. Kornienko K, et al. Prostate Cancer Prostatic Dis. 2022 Mar;25(1):109-116. doi: 10.1038/s41391-021-00478-2. Epub 2021 Dec 17. Prostate Cancer Prostatic Dis. 2022. PMID: 34916584 Free PMC article.
Addition of Standard Enzalutamide Medication Shows Synergistic Effects on Response to [177Lu]Lu-PSMA-617 Radioligand Therapy in mCRPC Patients with Imminent Treatment Failure-Preliminary Evidence of Pilot Experience.
Rosar F, Bader H, Bartholomä M, Maus S, Burgard C, Linxweiler J, Khreish F, Ezziddin S. Rosar F, et al. Among authors: linxweiler j. Cancers (Basel). 2022 May 29;14(11):2691. doi: 10.3390/cancers14112691. Cancers (Basel). 2022. PMID: 35681671 Free PMC article.
64 results